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Abstract 
Although chondroitin sulfate (CS) is known to act as an inhibitory axon guidance cue, retinal 
axons show substantial growth on a culture substrate containing CS.  Thus, the question arises 
as to how retinal axons elongate on CS-containing culture substrates.  To elucidate the effects 
of retinal axons on a substrate containing CS, we synthesized biotinylated CS (biotin-CS) and 
developed a culture substrate with streptavidin-conjugated biotin-CS (complex between 
streptavidin and biotin-CS) to culture retinal axons.  The effects of retinal axons on the 
streptavidin-biotin-CS complex were analyzed immunocytochemically using antibodies against 
CS and streptavidin, which recognize the carbohydrate and protein portions of the complex, 
respectively.  After the axons were cultured on the substrate, areas that were 
CS-immunonegative but streptavidin-immunopositive were observed on the surface, 
corresponding to areas with or without axons, respectively.  Absence of CS immunostaining 
was considered to be caused by structural alterations in the carbohydrate chains of the CS under 
the influence of the axons.   
 
Keywords: Retina, Axon, Chondroitin sulfate, Optic tract 
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Introduction 
Neuronal circuit formation is one of the basic themes in neuroscience.  Retinotectal 
projections are good models for studying axon guidance.  A series of guidance cues helps 
axons navigate along an appropriate path.  Chondroitin sulfate proteoglycans (CSPGs) are 
known to act as guidance cues or modulators that exert inhibitory effects on axonal growth at 
various decision points along the retinotectal pathway.  In the retina, CSPGs play roles in 
regulating the direction of axonal growth of retinal ganglion cells (RGCs) toward the central 
retina (Brittis et al. 1992).  CSPGs inhibit axonal growth of RGCs and contribute to 
retinotectal pathway formation (Ichijo and Kawabata 2001; Walz et al. 2002; Becker and 
Becker 2002).  CSPGs are involved in the formation of the dorsal midline barrier in the optic 
tectum (Wu et al. 1995).  In the mouse optic chiasm, whether RGCs project their axons 
ipsilaterally or contralaterally is influenced by chondroitin sulfate (CS) (Chung et al. 2000).  In 
the optic tract, early- and late-growing RGC axons run in the deep and superficial peripheral 
layers, respectively; thus, RGC axons are ordered chronologically.  Removal of CS disrupts 
this chronological order in the tract (Leung et al. 2003).   
 CSPGs consist of a core protein and carbohydrate chain of CS.  CS is a long 
unbranched polymer consisting of repeating disaccharide units of glucuronic acid and 
N-acetylgalactosamine.  The units show structural diversity, and the different types are 
designated A-, B-, C-, D-, and E-unit.  Some monoclonal antibodies recognize CSs.  One of 
them—MO-225—preferentially recognizes D-unit- and E-unit-rich CSs (Yamagata et al. 1987; 
Deepa et al. 2007).  The neuropil beneath the optic tract was labeled intensely with MO-225, 
suggesting that the MO-225-immunopositive neuropil delimits the boundary of the axonal 
pathway (Ichijo 2006).  However, retinal axons run in the deep layer of the optic tract in 
contact with the MO-225-immunopositive neuropil, which is thought to inhibit axonal growth.  
Moreover, retinal axons show substantial but not profuse growth on substrates with 
MO-225-immunopositive CS in vitro.  Thus, the question arises as to how axons elongate on a 
substrate containing MO-225-immunopositive CS.   
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 To examine whether retinal axons exert an influence on their microenvironment to 
promote their own growth, we synthesized biotinylated CS (biotin-CS).  In particular, 
D-unit-rich CS (CSD) was biotinylated (biotin-CSD) because it is recognized preferentially by 
MO-225.  We developed a streptavidin/biotin-CSD complex that mimics CSPG and made 
retinal axons grow on a substrate made of this complex.  The results indicated that the 
carbohydrate portion (CS) of the complex was altered under the influence of the axons.  This 
alteration of CS might be an adaptation of the axons to improve the microenvironment for their 
growth.  
 
Methods 
 All experimental protocols were approved by the Committee for Animal Care and 
Use of the University of Tsukuba.  The reducing ends of CSD (Seikagaku, Tokyo, Japan) were 
coupled chemically to biotin (Shinohara et al. 1995) to synthesize biotin-CSD.  Biotin-CSD 
had a conjugation efficiency of 21% and an average molecular weight of 20 kDa.  Biotin-CSD 
(10 µl of 0.75 µg/µl) was incubated with streptavidin (10 µl of 0.075 µg/µl) for 3 h at 37.5°C to 
form a complex consisting of a protein core and a carbohydrate chain.  An excess of 
biotin-CSD was used for complex formation because unconjugated CSD was also included in 
the preparation.  The mixtures (10 µl per lane) were electrophoresed on 10% non-denaturing 
polyacrylamide gels using a running buffer without sodium dodecyl sulfate.  After washing 
twice (in 25% ethanol, 7.5% acetic acid, and 0.1% sodium dodecyl sulfate) for 20 min, the gels 
were stained with SYPRO Ruby (Bio-Rad, Hercules, CA) and observed with a Fluoroimager 
595 (GE Healthcare Bio-Science, Piscataway, NJ).  Subsequently, the gels were stained with 
0.125% Alcian blue (Sigma-Aldrich, St. Louis, MO).  The Alcian blue-stained gels were 
photographed using an image scanner (Canon, Tokyo, Japan).   
 Glass coverslips were coated with poly-D-lysine (10 µg/ml) for 2 h at 37.5°C, 
washed, and air-dried.  The coverslips were coated with nitrocellulose dissolved in methanol 
and again coated with poly-D-lysine (Lagenaur and Lemmon 1987; Becker and Becker 2002).  
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Each coverslip was coated with 10 µl of the biotin-CSD (0.1 µg/µl) and streptavidin (0.01 
µg/µl) mixture and placed in a humid chamber overnight at 37.5°C.  The coverslips were 
washed in phosphate-buffered saline (PBS) and subsequently coated with laminin (40 µg/ml, 
Invitrogen, Carlsbad, CA) for 3 h at 37.5°C.  To confirm formation of the substrate, the 
coverslips were immunocytochemically double-stained with anti-CS monoclonal antibody 
MO-225 (Seikagaku) and anti-streptavidin polyclonal antibody (Abcam, Cambridge, UK) along 
with appropriate secondary antibodies (Invitrogen).  The substrate was then used for retinal 
explant culture.   
 Retinal explants were prepared from embryonic day 6 chicks, as described 
previously (Ichijo and Bonhoeffer 1998).  They were cultured on the substrate containing the 
streptavidin-biotin-CSD complex with F12 nutrient mixture supplemented with 8% fetal bovine 
serum, 2% chick serum, and 2 mM L-glutamine (Invitrogen) at 37.5°C in 4% CO2 for 2 days.  
The cultures were fixed with 3.7% formaldehyde in PBS at room temperature for 2 h.  In some 
cultures, the retinal axons were removed, either with forceps or by freeze-thawing, before 
fixation.  The cultures were washed with 0.5% Triton X-100 in PBS.   
To visualize the axons with microfilaments and microtubules under red fluorescence, we 
used a cocktail of Alexa594-phalloidin (Invitrogen) and anti-β-tubulin rabbit-polyclonal 
antibody (Lab Vision, Westinghouse, CA) with anti-rabbit IgG-conjugated Alexa594 
(Invitrogen).  The cultures were double-stained using the cocktail and MO-225 with 
anti-mouse IgG-conjugated Alexa488 (Invitrogen).  Some cultures were double-stained using 
MO-225 and anti-streptavidin polyclonal antibody along with appropriate secondary antibodies.  
All specimens were observed under a fluorescence microscope (DM-XRA2, Leica, Wetzlar, 
Germany).  Digital images were processed with Adobe Photoshop CS, by adjusting for 
contrast.   
 
Results 
Formation of streptavidin and biotin-CSD complex and development of a culture 
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substrate using this complex 
Biotin-CSD incubated with streptavidin was electrophoresed on non-denaturing gels (Fig. 1a).  
A broad band stained with both SYPRO Ruby and Alcian blue was observed, indicating 
formation of a complex between streptavidin and biotin-CSD.  Unlike the sharp band for 
streptavidin, the band for the complex was broad and in the higher molecular-weight range, 
which is thought to be because of the variation in the molecular weights and anionic charges of 
the complex with biotin-CSD of varying lengths (average molecular weight, 20 kDa).  Apart 
from the band corresponding to the complex, a smeared band was observed with Alcian Blue 
staining, but not with SYPRO Ruby staining.  This band represented unconjugated CSD 
because the efficiency of CS-biotinylation was only 21%.   
The substrate for axonal culture was prepared using the streptavidin-biotin-CSD complex.  
This substrate was double-stained with MO-225 and anti-streptavidin (Fig. 1b, c).  Both the 
antibodies showed uniform staining throughout the substrate, indicating an even distribution of 
the complex in the substrate, but no antibody staining was observed outside the substrate.   
Influence of retinal axons on culture substrate containing the streptavidin-biotin-CSD 
complex 
Distribution of the streptavidin-biotin-CSD complex on the substrate was assessed by staining 
with MO-225 and comparing with axonal paths (Fig. 2a–c).  In the cultures, some axons were 
labeled by MO-225 (Fig. 2a).  There were two populations of retinal axons with or without 
MO-225 staining in vitro as shown previously (Ichijo 2006).   
 There were areas on the substrate where MO-225 staining was absent along some but 
not all axons (Fig. 2a–c).  Areas where MO-225 staining was absent with no axons were also 
seen.  The MO-225-negative areas were aligned like axonal paths.  The MO-225-negative 
areas were observed only on the substrate with cultured axons.   
 Distribution of the complex was further examined by double staining the substrate 
with MO-225 and anti-streptavidin after mechanical removal of axons (Fig. 2d–f).  Aligned 
areas on the substrate where MO-225 staining was absent were seen.  However, the substrate 
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was uniformly stained with anti-streptavidin.  The uniform staining of anti-streptavidin 
indicated that the complex was distributed uniformly on the substrate, and that antibodies 
readily accessed the complex within the substrate from which axons were mechanically 
removed.  In the MO-225-negative areas, staining was absent in the carbohydrate portion of 
the complex, CS, but was present in the protein portion, streptavidin.   
 
Discussion 
Technical advantages of using the streptavidin-biotin-CSD complex in vitro 
Streptavidin and biotin-CSD efficiently formed a complex, which is thought to comprise a 
tetramer with a subunit of one streptavidin binding to one biotin-CSD (Green 1990).  This 
complex offers some advantages.  The CS in the complex is indirectly fixed because 
streptavidin is fixable with formaldehyde, which made it possible to examine detailed 
distribution of the complex.  The absence of MO-225 staining in some regions of the substrate 
was not due to the uneven distribution of the complex because this was observed only with the 
axons cultured on the complex.  Moreover, the uniform anti-streptavidin staining on the 
substrate confirmed that the absence of MO-225 staining was not caused by the inability of the 
antibody to access the complex.  The double immunostaining using the antibodies against CS 
and streptavidin indicated that the complex was under the influence of the growing axons in 
vitro.  This method enabled us to examine whether the axons exert their influence on the 
microenvironment for their growth.  In addition, the complex will be useful to investigate the 
relationship between the structural diversity of CS and its functional specificity because the 
combination of each biotin-CS and streptavidin will produce a complex with CS of a different 
structure.   
The influence of axons on the streptavidin-biotin-CSD complex in the substrate in vitro 
 Some areas on the substrate were stained with anti-streptavidin but not with MO-225.  
The MO-225 staining was absent along some, but not all, axons on the substrate (Fig. 2a–c).  
After mechanical removal of the axons, the areas without MO-225 staining were distinct (Fig. 
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2d).  This might be because some of the axons labeled with MO-225 (Fig. 2a) might have 
masked the areas without MO-225 staining in the substrate.  Further, some areas without 
MO-225 staining did not contain axons, but were aligned like axon paths (Fig. 2a).  This 
“axon-less” path was likely to be caused by the tracks of the axons that had grown and then 
retracted.  However, it is unlikely that these could have formed due to the deliberate removal 
of axons during the staining procedure because such areas usually have remnants of the axons 
(Fig. 2d–f).   
 The results indicated that the carbohydrate portion of the complex in the substrate, 
CS, was altered under the influence of the axons.  MO-225 immunostaining was absent in the 
carbohydrate portion of the complex.  The absence of immunostaining is thought to be caused 
by structural alteration of the CS chains.  The results suggest two possibilities.  (1) CS chains 
might be cleaved and removed, for example, by enzymes like hyaluronidases or chondroitinases 
(Stern and Jedrzejas 2006); or (2) the epitopes of MO-225 might be modified due to the addition 
or removal of sulfate groups on the CS chains (Morimoto-Tomita et al. 2002; Nagamine et al. 
2005).   
 The protein portion of the substrate complex in the substraet, streptavidin, was not 
altered (Fig. 2e) although axons are known to release proteolytic enzymes during their growth 
(Krystosek and Seeds 1981; Seeds et al. 1997; Webber et al. 2002; Pizzi and Crowe 2007).  
This might be due to the specificity of antibody detection, i.e., polypeptides bearing epitopes 
recognized by the polyclonal anti-streptavidin antibody remained on the substrate even after 
their partial degradation.   
Functional significance of the alteration of biotin-CSD under the influence of retinal axons 
 It has been suggested that the neuropil, with MO-225-immunopositive CS, delimits 
the boundary of the axonal pathway beneath the optic tract due to the inhibitory effects of CS on 
axonal growth (Ichijo 2006).  However, retinal axons run in contact with the 
MO-225-immunopositive neuropil in the deep layer of the optic tract in vivo.  Here, we 
showed that in vitro some retinal axons grow on substrates by altering MO-225-immunopositive 
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biotin-CSD.  This alteration might be an adaptation of the retinal axons to improve the 
microenvironment for their growth; this might also be the case in vivo when retinal axons grow 
in contact with the MO-225-immunopositive neuropil in the deep layer of the optic tract.   
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Figure legends 
Fig. 1 
Substrate comprising a complex of streptavidin and biotin-CSD.  a Non-denaturing 
polyacrylamide gel double-stained with SYPRO Ruby (1-3) or Alcian blue (1’-3’).  Samples 
loaded are shown below each lanes: 1,1’ streptavidin; 2,2’ biotin-CSD; 3,3’ mixed solution with 
streptavidin and biotin-CSD.  Open arrowheads Complex of streptavidin and biotin-CSD, 
closed arrowhead streptavidin, asterisk unconjugated CSD.  b, c Substrate of the 
streptavidin-biotin-CSD complex is shown.  The substrate is double-stained with MO-225 (b) 
and anti-streptavidin (c).  Broken lines Boundary of the coating.  Bars 20 µm.    
Fig. 2 
Streptavidin-biotin-CSD complex under the influence of retinal axons in vitro.  a-c Retinal 
culture on streptavidin-biotin-CSD complex substrate, Staining: a MO-225, b axons, c merged 
image.  Arrows indicate absence of MO-225 staining under the axons, arrowheads indicate 
absence of MO-225 staining with no axons; the MO-225-negative areas are aligned like axon 
paths.  d-f After mechanical removal of axons.  Staining: d MO-225 staining, e 
anti-streptavidin staining, f merged image.  Open arrowheads indicate the absence of MO-225 
staining and presence of anti-streptavidin staining along the axon paths.  Bars 20 µm.    
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